PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

PerkinElmer Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023 at 2:15 p.m. ET.

Steve Willoughby, senior vice president, investor relations & head of ESG, and Alan Fletcher, senior vice president, Life Sciences, will provide an update on the Company and its strategic priorities. To register, click here.

A live audio webcast will be available on the Events section of the Company’s website at www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer Investor Relations website after the event and will be available for at least 30 days.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $4.6 billion in 2022, has more than 16,000 employees serving customers in 190 countries, and is a component of the S&P 500 Index. Additional information is available at www.perkinelmer.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.05
-4.95 (-1.95%)
AAPL  270.32
+1.27 (0.47%)
AMD  251.72
-7.93 (-3.06%)
BAC  53.48
-0.08 (-0.14%)
GOOG  278.15
-5.97 (-2.10%)
META  627.70
-10.01 (-1.57%)
MSFT  513.36
-3.67 (-0.71%)
NVDA  199.04
-7.84 (-3.79%)
ORCL  245.39
-12.46 (-4.83%)
TSLA  447.29
-21.08 (-4.50%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.